Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taro Takami

Showing results (171-180 of 175) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 175 results.
Journal of Gastroenterology|June 20, 2025
Pretreatment serum angiopoietin-2 predicts prognosis and liver functional reserve after successful HCV eradication with sofosbuvir and velpatasvir in patients with HCV-related decompensated cirrhosisNaoki Kawagishi, Goki Suda, Yuki Tahata, et al.
Journal of Gastroenterology|January 21, 2022
Liver-related events after direct-acting antiviral therapy in patients with hepatitis C virus-associated cirrhosisYuki Tahata, Hayato Hikita, Satoshi Mochida, et al.
International Journal of Molecular Sciences|July 17, 2020
Common Drug Pipelines for the Treatment of Diabetic Nephropathy and Hepatopathy: Can We Kill Two Birds with One Stone?Yoshio Sumida, Masashi Yoneda, Hidenori Toyoda, et al.
Journal of Gastroenterology|October 13, 2023
Posttreatment liver function, but not baseline liver function stratifies patient survival after direct-acting antiviral treatment in decompensated cirrhosis with hepatitis C virusYuki Tahata, Hayato Hikita, Satoshi Mochida, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 29, 2024
Factors involved in gastroesophageal varix-related events in patients with hepatitis C virus-related compensated and decompensated cirrhosis after direct-acting antiviral therapyYuki Tahata, Hayato Hikita, Satoshi Mochida, et al.
Pageof 18

Showing results (171-180 of 175) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 175 results.
Journal of Gastroenterology|June 20, 2025
Pretreatment serum angiopoietin-2 predicts prognosis and liver functional reserve after successful HCV eradication with sofosbuvir and velpatasvir in patients with HCV-related decompensated cirrhosisNaoki Kawagishi, Goki Suda, Yuki Tahata, et al.
Journal of Gastroenterology|January 21, 2022
Liver-related events after direct-acting antiviral therapy in patients with hepatitis C virus-associated cirrhosisYuki Tahata, Hayato Hikita, Satoshi Mochida, et al.
International Journal of Molecular Sciences|July 17, 2020
Common Drug Pipelines for the Treatment of Diabetic Nephropathy and Hepatopathy: Can We Kill Two Birds with One Stone?Yoshio Sumida, Masashi Yoneda, Hidenori Toyoda, et al.
Journal of Gastroenterology|October 13, 2023
Posttreatment liver function, but not baseline liver function stratifies patient survival after direct-acting antiviral treatment in decompensated cirrhosis with hepatitis C virusYuki Tahata, Hayato Hikita, Satoshi Mochida, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 29, 2024
Factors involved in gastroesophageal varix-related events in patients with hepatitis C virus-related compensated and decompensated cirrhosis after direct-acting antiviral therapyYuki Tahata, Hayato Hikita, Satoshi Mochida, et al.
Pageof 18